TQx is delivering safe in vivo cell & gene therapies to make challenging diseases curable – for everyone

TQ Therapeutics is offering their CELLfinity platform, a modular target cell-specific modification platform for the generation of infinite in vivo cell & gene therapy product opportunities. 

The modular platform is based on TQx‘s proprietary EXiVO approach -  an extracorporeal in-vivo gene therapy. This new generation of autologous mRNA-T-cell therapeutics are designed to revolutionize several treatment areas across indications, without abandoning the advantages of safe autologous cell therapy

TQ Therapeutics

Org chart

Teams

Offices

TQ Therapeutics

Org chart

Teams

Offices

Related companies